Unknown PHASE2 INTERVENTIONAL 2-arm NCT02866552

SCLERoderma et Adipose-DErived Stroma Cells (SCLERADECIII)

Sponsor: Assistance Publique Hopitaux De Marseille

Interventions Ringer lactate Stromal Vascular fraction

Updated 6 times since 2017 Last updated: Aug 10, 2016 Started: Jan 31, 2017 Primary completion: Jan 31, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Systemic Sclerosis, this trial is ongoing. The trial is conducted by Assistance Publique Hopitaux De Marseille and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Sep 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Sep 2019 [monthly]

Not Yet Recruiting PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique Hopitaux De Marseille

Data source: Assistance Publique Hopitaux De Marseille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marseille, France